Human KIR3DL1 (Killer cell immunoglobulin-like receptor 3DL1) ELISA Kit
Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
Human KIR3DL1 (Killer cell immunoglobulin-like receptor 3DL1) ELISA Kit
Category
ELISA Kits
Provider
FineTest
Reference
EH9634
Tested Applications
ELISA
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | ELISA Kits |
| Reactivity | Human |
| Detection Method | Colorimetric |
| Assay Data | 4 hours |
| Assay Type | Sandwich ELISA, Double Antibody |
| Test Range | 0.156-10ng/ml |
| Sensitivity | 0.094ng/ml |
| Size 1 | 96T |
| Tested Applications | ELISA |
| Sample Type | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Availability | Shipped within 10-14 working days. |
| Storage | 2-8 °C for 12 months |
| UniProt ID | P43629 |
| Alias | CD158 antigen-like family member E,HLA-BW4-specific inhibitory NK cell receptor,CD158E,NKAT3,NKB1Natural killer-associated transcript 3,KIR,NKB1,NKAT3,NKB1B,NKAT-3,CD158E1,KIR2DL5B,KIR3DL1/S1 |
| Background | Elisa kits for KIR3DL1 |
| Status | RUO |
Background
Killer Cell Immunoglobulin-Like Receptor 3DL1 (KIR3DL1) is a member of the KIR family, expressed on natural killer (NK) cells and a subset of T lymphocytes, playing a critical role in modulating immune responses. This receptor binds specifically to HLA class I molecules, particularly HLA-B alleles with the Bw4 motif, allowing NK cells to recognize and monitor the health of target cells. When KIR3DL1 engages its ligand, it delivers inhibitory signals that suppress NK cell cytotoxic activity, thus maintaining immune homeostasis and preventing autoreactivity. Variations in KIR3DL1, including polymorphisms and expression levels, are associated with differential susceptibility to infectious diseases, cancer, and autoimmune conditions. Studies have also highlighted its significance in allogeneic hematopoietic stem cell transplantation, where KIR-HLA mismatches can influence graft-versus-leukemia effects and transplantation outcomes. By regulating NK cell activity, KIR3DL1 contributes to the delicate balance between immune surveillance and tolerance, making it a valuable target for therapeutic interventions in cancer immunotherapy and immune-mediated disorders.
Productos relacionados
Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1) Antibody
KIR3DL1 Antibody is a Rabbit Polyclonal antibody against KIR3DL1. Killer cell immunoglobulin-like receptors (KIRs) are t…
Ver producto
Human Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1) Protein
Human Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1) is a recombinant Human protein expressed in E. coli.…
Ver producto
Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1) Antibody
Polyclonal Antibody to Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1).…
Ver producto